SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Fernando Perez-Ruiz, Nicola Dalbeth, Tomas Bardin, A Review of Uric Acid, Crystal Deposition Disease, and Gout, Advances in Therapy, 2015, 32, 1, 31

    CrossRef

  2. 2
    Gemma E. Shields, Stephen M. Beard, A Systematic Review of the Economic and Humanistic Burden of Gout, PharmacoEconomics, 2015,

    CrossRef

  3. 3
    Trinidad Montero-Melendez, ACTH: The forgotten therapy, Seminars in Immunology, 2015,

    CrossRef

  4. 4
    Philip C Robinson, Nicola Dalbeth, Advances in pharmacotherapy for the treatment of gout, Expert Opinion on Pharmacotherapy, 2015, 16, 4, 533

    CrossRef

  5. 5
    S. Mantarro, A. Capogrosso-Sansone, M. Tuccori, C. Blandizzi, S. Montagnani, I. Convertino, L. Antonioli, M. Fornai, I. Cricelli, S. Pecchioli, C. Cricelli, F. Lapi, Allopurinol adherence among patients with gout: an Italian general practice database study, International Journal of Clinical Practice, 2015, 69, 6
  6. 6
    Janna ter Schure, Hans van der Wouden, Chronische jicht: urinezuurverlagende therapie met profylaxe?, Huisarts en wetenschap, 2015, 58, 2, 110

    CrossRef

  7. 7
    Anastasia Slobodnick, Binita Shah, Michael H. Pillinger, Svetlana Krasnokutsky, Colchicine: Old and New, The American Journal of Medicine, 2015, 128, 5, 461

    CrossRef

  8. 8
    Dong-Jin Park, Ji-Hyoun Kang, Jeong-Won Lee, Kyung-Eun Lee, Lihui Wen, Tae-Jong Kim, Yong-Wook Park, Sung-Hwan Park, Shin-Seok Lee, Cost-Effectiveness Analysis of HLA–B5801 Genotyping in the Treatment of Gout Patients With Chronic Renal Insufficiency in Korea, Arthritis Care & Research, 2015, 67, 2
  9. 9
    Samya Mohammad, Stephanie L. Giattino, Robert T. Keenan, Current and Emerging Therapies for Gout, Current Treatment Options in Rheumatology, 2015, 1, 2, 143

    CrossRef

  10. 10
    Hyo Jin Choi, Chan Hee Lee, Joo Hyun Lee, Bo Young Yoon, Hyoun Ah Kim, Chang Hee Suh, Sang Tae Choi, Jung Soo Song, Ho Yeon Joo, Sung Jae Choi, Ji Soo Lee, Kee Chul Shin, Han Joo Baek, Current gout treatment and flare in South Korea: Prophylactic duration associated with fewer gout flares, International Journal of Rheumatic Diseases, 2015, 18, 4
  11. 11
    J. Sautner, Diagnose und Therapiestandard der Gicht in Österreich, rheuma plus, 2015, 14, 1, 18

    CrossRef

  12. 12
    Joseph Turner, Dylan Cooper, Does Colchicine Improve Pain in an Acute Gout Flare?, Annals of Emergency Medicine, 2015,

    CrossRef

  13. 13
    Puja P. Khanna, John FitzGerald, Evolution of management of gout, Current Opinion in Rheumatology, 2015, 27, 2, 139

    CrossRef

  14. 14
    Sneha Pai, Ashraf Raslan, Naomi Schlesinger, Gout: Update on Current Therapeutics, Current Treatment Options in Rheumatology, 2015, 1, 2, 131

    CrossRef

  15. 15
    L. Sellin, J.T. Kielstein, K. de Groot, Hyperurikämie – mehr als Gicht, Zeitschrift für Rheumatologie, 2015, 74, 4, 322

    CrossRef

  16. 16
    Nicholas J. Kennedy, Paul J. Healy, Andrew A. Harrison, Inpatient management of gout in a New Zealand hospital: a retrospective audit, International Journal of Rheumatic Diseases, 2015, 18, 4
  17. 17
    Alexandre Dumusc, Alexander So, Interleukin-1 as a therapeutic target in gout, Current Opinion in Rheumatology, 2015, 27, 2, 156

    CrossRef

  18. 18
    Gail S. Kerr, John S. Richards, Carl A. Nunziato, Olga V. Patterson, Scott L. DuVall, Mireille Aujero, David Maron, Richard Amdur, Measuring Physician Adherence With Gout Quality Indicators: A Role for Natural Language Processing, Arthritis Care & Research, 2015, 67, 2
  19. 19
    R. Ramonda, F. Oliviero, P. Galozzi, P. Frallonardo, M. Lorenzin, A. Ortolan, A. Scanu, L. Punzi, Molecular mechanisms of pain in crystal-induced arthritis, Best Practice & Research Clinical Rheumatology, 2015,

    CrossRef

  20. 20
    Hyon K. Choi, Jingbo Niu, Tuhina Neogi, Clara A. Chen, Christine Chaisson, David Hunter, Yuqing Zhang, Nocturnal Risk of Gout Attacks, Arthritis & Rheumatology, 2015, 67, 2
  21. 21
    J. Sautner, G. Eichbauer-Sturm, J. Gruber, R. Puchner, P. Spellitz, C. Strehblow, J. Zwerina, G. Eberl, Österreichische Ernährungs- und Lebensstilempfehlungen bei Gicht und Hyperurikämie, Zeitschrift für Rheumatologie, 2015,

    CrossRef

  22. 22
    Navine Nasser-Ghodsi, Leslie R. Harrold, Overcoming adherence issues and other barriers to optimal care in gout, Current Opinion in Rheumatology, 2015, 27, 2, 134

    CrossRef

  23. 23
    Nazia Rashid, Gerald D. Levy, Yi-Lin Wu, Chengyi Zheng, River Koblick, T. Craig Cheetham, Patient and clinical characteristics associated with gout flares in an integrated healthcare system, Rheumatology International, 2015,

    CrossRef

  24. 24
    Rebecca L Roberts, Lisa K Stamp, Pharmacogenetic considerations in the treatment of gout, Pharmacogenomics, 2015, 16, 6, 619

    CrossRef

  25. 25
    Hamid Mustafa, Pitfalls in management of acute gouty attack, a qualitative research conducted in Makah Region – Saudi Arabia, Alexandria Journal of Medicine, 2015, 51, 2, 121

    CrossRef

  26. You have free access to this content26
    Rebecca Grainger, Andrew A. Harrison, Rules of engagement: turning recommendations into results in the diagnosis and management of gout, International Journal of Rheumatic Diseases, 2015, 18, 3
  27. 27
    Arrigo Francesco Giuseppe Cicero, Giovambattista Desideri, Giulia Grossi, Riccardo Urso, Martina Rosticci, Sergio D’Addato, Claudio Borghi, Serum uric acid and impaired cognitive function in a cohort of healthy young elderly: data from the Brisighella Study, Internal and Emergency Medicine, 2015, 10, 1, 25

    CrossRef

  28. 28
    Sharan K. Rai, Lindsay C. Burns, Mary A. De Vera, Aliya Haji, Dean Giustini, Hyon K. Choi, The economic burden of gout: A systematic review, Seminars in Arthritis and Rheumatism, 2015,

    CrossRef

  29. 29
    Ashika Chhana, Nicola Dalbeth, The Gouty Tophus: a Review, Current Rheumatology Reports, 2015, 17, 3

    CrossRef

  30. 30
    Sébastien Ottaviani, Philippe Dieudé, Tuberculous Cervical Lymphadenitis in a Gouty Patient Treated With Anakinra, JCR: Journal of Clinical Rheumatology, 2015, 21, 4, 230

    CrossRef

  31. 31
    Sébastien Ottaviani, Ghislaine Gill, Aurore Aubrun, Elisabeth Palazzo, Olivier Meyer, Philippe Dieudé, Ultrasound in gout: A useful tool for following urate-lowering therapy, Joint Bone Spine, 2015, 82, 1, 42

    CrossRef

  32. 32
    Tomas Cazenave, Carlos Pineda, Anthony M. Reginato, Marwin Gutierrez, Ultrasound-Guided Procedures in Rheumatology. What Is the Evidence?, JCR: Journal of Clinical Rheumatology, 2015, 21, 4, 201

    CrossRef

  33. 33
    Keith Rome, Mike Frecklington, Management of Chronic Conditions in the Foot and Lower Leg, 2015,

    CrossRef

  34. 34
    A. J. Teichtahl, L. Clemens, M. Nikpour, E. Romas, A prospective study of acute inpatient gout diagnoses and management in a tertiary hospital: the determinants and outcome of a rheumatology consultation, Internal Medicine Journal, 2014, 44, 11
  35. 35
    Dimitrios Daoussis, Ioannis Antonopoulos, Andrew P. Andonopoulos, ACTH as a treatment for acute crystal-induced arthritis: Update on clinical evidence and mechanisms of action, Seminars in Arthritis and Rheumatism, 2014, 43, 5, 648

    CrossRef

  36. 36
    George Nuki, An appraisal of the 2012 American College of Rheumatology Guidelines for the Management of Gout, Current Opinion in Rheumatology, 2014, 26, 2, 152

    CrossRef

  37. 37
    A.-K. Tausche, M. Christoph, M. Forkmann, U. Richter, S. Kopprasch, C. Bielitz, M. Aringer, C. Wunderlich, As compared to allopurinol, urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout, Rheumatology International, 2014, 34, 1, 101

    CrossRef

  38. 38
    Trinidad Montero-Melendez, Mila F.M. Madeira, Lucy V. Norling, Asil Alsam, Michael A. Curtis, Tarcília A. da Silva, Mauro Perretti, Association between Periodontal Disease and Inflammatory Arthritis Reveals Modulatory Functions by Melanocortin Receptor Type 3, The American Journal of Pathology, 2014, 184, 8, 2333

    CrossRef

  39. 39
    Fernando Perez-Ruiz, Sandra P Chinchilla, Ana María Herrero-Beites, Canakinumab for gout: a specific, patient-profiled indication, Expert Review of Clinical Immunology, 2014, 10, 3, 339

    CrossRef

  40. 40
    Stefan M. Nidorf, John W. Eikelboom, Peter L. Thompson, Colchicine for Secondary Prevention of Cardiovascular Disease, Current Atherosclerosis Reports, 2014, 16, 3

    CrossRef

  41. 41
    Y.-K. Zhang, H. Yang, J.-Y. Zhang, L.-J. Song, Y.-C. Fan, Comparison of intramuscular compound betamethasone and oral diclofenac sodium in the treatment of acute attacks of gout, International Journal of Clinical Practice, 2014, 68, 5
  42. You have free access to this content42
    Liza Wilson, Kavita V. Nair, Joseph J. Saseen, Comparison of New-Onset Gout in Adults Prescribed Chlorthalidone vs Hydrochlorothiazide for Hypertension, The Journal of Clinical Hypertension, 2014, 16, 12
  43. 43
    J. Sautner, Diagnose und Therapiestandard der Gicht in Österreich, Zeitschrift für Rheumatologie, 2014, 73, 9, 836

    CrossRef

  44. 44
    Sébastien Ottaviani, Ghislaine Gill, Aurore Aubrun, Elisabeth Palazzo, Olivier Meyer, Philippe Dieudé, Échographie dans la goutte : un outil utile dans le suivi du traitement hypouricémiant, Revue du Rhumatisme, 2014, 81, 6, 491

    CrossRef

  45. 45
    Matthew W. Davis, Suman Wason, Effect of Steady-State Atorvastatin on the Pharmacokinetics of a Single Dose of Colchicine in Healthy Adults Under Fasted Conditions, Clinical Drug Investigation, 2014, 34, 4, 259

    CrossRef

  46. 46
    Tristan Pascart, Emmanuel Biver, Cécile Wibaux, Audrey Juillard, Bernard Cortet, René-Marc Flipo, Étude des hospitalisations pour goutte dans un service de rhumatologie entre 2000 et 2010 – Analyse rétrospective de 114 observations, Revue du Rhumatisme, 2014, 81, 1, 35

    CrossRef

  47. 47
    Michael George, Sally Pullman-Mooar, Fauzia Hussain, H. Ralph Schumacher, Evaluating Appropriate Use of Prophylactic Colchicine for Gout Flare Prevention, Arthritis Care & Research, 2014, 66, 8
  48. 48
    Harmanjot K Grewal, Joseph R Martinez, Luis R Espinoza, Febuxostat: drug review and update, Expert Opinion on Drug Metabolism & Toxicology, 2014, 10, 5, 747

    CrossRef

  49. 49
    Eric Rymal, Denise Rizzolo, Gout, Journal of the American Academy of Physician Assistants, 2014, 27, 9, 26

    CrossRef

  50. 50
    Tristan Pascart, Erwan Oehler, René-Marc Flipo, Gout in French Polynesia: A survey of common practices, Joint Bone Spine, 2014, 81, 4, 374

    CrossRef

  51. 51
    Philip C. Robinson, Simon Horsburgh, Gout: Joints and beyond, epidemiology, clinical features, treatment and co-morbidities, Maturitas, 2014, 78, 4, 245

    CrossRef

  52. 52
    Lili Ma, Lei Wei, Huiyong Chen, Zhuojun Zhang, Qiang Yu, Zongfei Ji, Lindi Jiang, Influence of urate-lowering therapies on renal handling of uric acid, Clinical Rheumatology, 2014,

    CrossRef

  53. 53
    Mark C. Fisher, Michael H. Pillinger, Robert T. Keenan, Inpatient Gout: A Review, Current Rheumatology Reports, 2014, 16, 11

    CrossRef

  54. 54
    Tristan Pascart, Erwan Oehler, René-Marc Flipo, La goutte en Polynésie française : enquête sur la pratique quotidienne, Revue du Rhumatisme, 2014, 81, 4, 352

    CrossRef

  55. 55
    Nicola Dalbeth, Thomas J. Lauterio, Henry R. Wolfe, Mechanism of Action of Colchicine in the Treatment of Gout, Clinical Therapeutics, 2014, 36, 10, 1465

    CrossRef

  56. 56
    Logan Carr, Sebastian Brooke, John Ingraham, Medically managed gout precipitating acute carpal tunnel syndrome, HAND, 2014,

    CrossRef

  57. 57
    Mary A. Vera, Greg Marcotte, Sharan Rai, Jessica S. Galo, Vidula Bhole, Medication Adherence in Gout: A Systematic Review, Arthritis Care & Research, 2014, 66, 10
  58. 58
    F. Sivera, M. Andres, L. Carmona, A. S. R. Kydd, J. Moi, R. Seth, M. Sriranganathan, C. van Durme, I. van Echteld, O. Vinik, M. D. Wechalekar, D. Aletaha, C. Bombardier, R. Buchbinder, C. J. Edwards, R. B. Landewe, J. W. Bijlsma, J. C. Branco, R. Burgos-Vargas, A. I. Catrina, D. Elewaut, A. J. L. Ferrari, P. Kiely, B. F. Leeb, C. Montecucco, U. Muller-Ladner, M. Ostergaard, J. Zochling, L. Falzon, D. M. van der Heijde, Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative, Annals of the Rheumatic Diseases, 2014, 73, 2, 328

    CrossRef

  59. 59
    Frances Rees, Michelle Hui, Michael Doherty, Optimizing current treatment of gout, Nature Reviews Rheumatology, 2014, 10, 5, 271

    CrossRef

  60. 60
    Judith Sautner, Johann Gruber, Manfred Herold, Jochen Zwerina, Burkhard F. Leeb, Österreichische 3e-Empfehlungen zu Diagnose und Management von Gicht 2013, Wiener klinische Wochenschrift, 2014, 126, 3-4, 79

    CrossRef

  61. 61
    Pascal Richette, Aline Frazier, Thomas Bardin, Pharmacokinetics considerations for gout treatments, Expert Opinion on Drug Metabolism & Toxicology, 2014, 10, 7, 949

    CrossRef

  62. 62
    Gary. M. Oderda, Aki Shiozawa, Michael Walsh, Kyle Hess, Diana. I. Brixner, Michael Feehan, Kasem Akhras, Physician Adherence to ACR Gout Treatment Guidelines: Perception Versus Practice, Postgraduate Medicine, 2014, 126, 3, 257

    CrossRef

  63. 63
    T. M. MacDonald, I. Ford, G. Nuki, I. S. Mackenzie, R. De Caterina, E. Findlay, J. Hallas, C. J. Hawkey, S. Ralston, M. Walters, J. Webster, J. McMurray, F. Perez Ruiz, C. G. Jennings, T. MacDonald, I. Ford, G. Nuki, I. Mackenzie, J. Hallas, J. Webster, M. Walters, S. Ralston, C. Hawkey, R. De Caterina, F. Perez-Ruiz, E. Findlay, J. McMurray, A. Maseri, G. Murray, H. Bird, J. McMurray, M. Petrie, M. MacDonald, P. Jhund, W. Saywood, R. Flynn, I. Ford, S. Kean, Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia, BMJ Open, 2014, 4, 7, e005354

    CrossRef

  64. 64
    Y. Kang, M. J. Kim, H. N. Jang, E. J. Bae, S. Yun, H. S. Cho, S.-H. Chang, D. J. Park, Rhabdomyolysis associated with initiation of febuxostat therapy for hyperuricaemia in a patient with chronic kidney disease, Journal of Clinical Pharmacy and Therapeutics, 2014, 39, 3
  65. 65
    Lisa K. Stamp, Safety profile of anti-gout agents, Current Opinion in Rheumatology, 2014, 26, 2, 162

    CrossRef

  66. 66
    Hadar Duskin-Bitan, Eytan Cohen, Elad Goldberg, Tzippy Shochat, Amos Levi, Moshe Garty, Ilan Krause, The degree of asymptomatic hyperuricemia and the risk of gout. A retrospective analysis of a large cohort, Clinical Rheumatology, 2014, 33, 4, 549

    CrossRef

  67. 67
    Haiyan Chen, Shucong Zheng, Yuankai Wang, Huiqing Zhu, Qiong Liu, Yu Xue, Jianhua Qiu, Hejian Zou, Xiaoxia Zhu, The effect of resveratrol on the recurrent attacks of gouty arthritis, Clinical Rheumatology, 2014,

    CrossRef

  68. 68
    Haiyan Chen, Shucong Zheng, Yuankai Wang, Huiqing Zhu, Qiong Liu, Yu Xue, Jianhua Qiu, Hejian Zou, Xiaoxia Zhu, The effect of resveratrol on the recurrent attacks of gouty arthritis, Clinical Rheumatology, 2014,

    CrossRef

  69. 69
    L. Cavagna, W. J. Taylor, The Emerging Role of Biotechnological Drugs in the Treatment of Gout, BioMed Research International, 2014, 2014, 1

    CrossRef

  70. 70
    Davide Grassi, Roberto Pontremoli, Raffaella Bocale, Claudio Ferri, Giovambattista Desideri, Therapeutic Approaches to Chronic Hyperuricemia and Gout, High Blood Pressure & Cardiovascular Prevention, 2014, 21, 4, 243

    CrossRef

  71. 71
    Naomi Schlesinger, Treatment of Acute Gout, Rheumatic Disease Clinics of North America, 2014, 40, 2, 329

    CrossRef

  72. 72
    Puja P. Khanna, Heather S. Gladue, Manjit K. Singh, John D. FitzGerald, Sangmee Bae, Shraddha Prakash, Marian Kaldas, Maneesh Gogia, Veronica Berrocal, Whitney Townsend, Robert Terkeltaub, Dinesh Khanna, Treatment of acute gout: A systematic review, Seminars in Arthritis and Rheumatism, 2014, 44, 1, 31

    CrossRef

  73. 73
    Tristan Pascart, Pascal Richette, René-Marc Flipo, Treatment of Nongout Joint Deposition Diseases: An Update, Arthritis, 2014, 2014, 1

    CrossRef

  74. 74
    Anne-Kathrin Tausche, Monika Reuss-Borst, Ute Koch, Urate Lowering Therapy with Febuxostat in Daily Practice—A Multicentre, Open-Label, Prospective Observational Study, International Journal of Rheumatology, 2014, 2014, 1

    CrossRef

  75. 75
    Monika Reuss-Borst, Was ist neu in der Diagnostik und Therapie der Gicht?, MMW - Fortschritte der Medizin, 2014, 156, 20, 58

    CrossRef

  76. 76
    Jian-Ming Lü, Qizhi Yao, Changyi Chen, 3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: A potential therapeutic agent for treatment of hyperuricemia and gout, Biochemical Pharmacology, 2013, 86, 9, 1328

    CrossRef

  77. 77
    Alexa Simon Meara, Lee S. Simon, Advice from Professional Societies: Appropriate Use of NSAIDs, Pain Medicine, 2013, 14,
  78. 78
    R. Terkeltaub, Are cherries now ripe for use as a complementary therapeutic in gout? Appraisal of the state of evidence, Evidence-Based Medicine, 2013, 18, 6, 230

    CrossRef

  79. 79
    Katherine A. Lyseng-Williamson, Canakinumab: A Guide to Its Use in Acute Gouty Arthritis Flares, BioDrugs, 2013, 27, 4, 401

    CrossRef

  80. 80
    Seoyoung C. Kim, Bernhard M. W. Schmidt, Jessica M. Franklin, Jun Liu, Daniel H. Solomon, Sebastian Schneeweiss, Clinical and Health Care Use Characteristics of Patients Newly Starting Allopurinol, Febuxostat, and Colchicine for the Treatment of Gout, Arthritis Care & Research, 2013, 65, 12
  81. 81
    Hyo Jin Choi, Seung Kak Shin, Mi Ryung Seo, Hee Jung Ryu, Han Joo Baek, Duration of Prophylactic Therapy Affects the Frequency of Gout Flare, Journal of Rheumatic Diseases, 2013, 20, 1, 17

    CrossRef

  82. 82
    Tristan Pascart, René-Marc Flipo, Gout: from international guidelines to current practice. Results from a physician questionnaire, Clinical Rheumatology, 2013, 32, 11, 1693

    CrossRef

  83. 83
    Robert Terkeltaub, Gout: Multinational gout guidelines: how do we move beyond 'déjà vu'?, Nature Reviews Rheumatology, 2013, 9, 10, 567

    CrossRef

  84. 84
    T. Bardin, G. Desideri, How to manage patients with gout, Current Medical Research and Opinion, 2013, 29, S3, 17

    CrossRef

  85. 85
    Elizabeth Cottrell, Valerie Crabtree, John J Edwards, Edward Roddy, Improvement in the management of gout is vital and overdue: an audit from a UK primary care medical practice, BMC Family Practice, 2013, 14, 1, 170

    CrossRef

  86. 86
    Jung-Soo Song, Jae-Bum Jun, Korean Guidelines for Tailored Management of Gout, Journal of Rheumatic Diseases, 2013, 20, 5, 280

    CrossRef

  87. 87
    Leslie Harrold, New developments in gout, Current Opinion in Rheumatology, 2013, 25, 3, 304

    CrossRef

  88. 88
    Dinesh Khanna, Heather Gladue, Richard Channick, Lorinda Chung, Oliver Distler, Daniel E. Furst, Eric Hachulla, Marc Humbert, David Langleben, Stephen C. Mathai, Rajeev Saggar, Scott Visovatti, Nezam Altorok, Whitney Townsend, John FitzGerald, Vallerie V. McLaughlin, Recommendations for Screening and Detection of Connective Tissue Disease–Associated Pulmonary Arterial Hypertension, Arthritis & Rheumatism, 2013, 65, 12
  89. 89
    Tran H. Tran, Jacqueline T. Pham, Hira Shafeeq, Kendra R. Manigault, Vibhuti Arya, Role of Interleukin-1 Inhibitors in the Management of Gout, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013, 33, 7
  90. 90
    David B. Mount, The kidney in hyperuricemia and gout, Current Opinion in Nephrology and Hypertension, 2013, 22, 2, 216

    CrossRef

  91. 91
    Puja P Khanna, Dinesh Khanna, Gout, 2013,

    CrossRef

  92. 92
    A. Cotten, T. Pascart, B. Cortet, Imagerie Musculosquelettique : Pathologies Générales, 2013,

    CrossRef

  93. 93
    Dinesh Khanna, John D. Fitzgerald, Puja P. Khanna, Sangmee Bae, Manjit K. Singh, Tuhina Neogi, Michael H. Pillinger, Joan Merill, Susan Lee, Shraddha Prakash, Marian Kaldas, Maneesh Gogia, Fernando Perez-Ruiz, Will Taylor, Frédéric Lioté, Hyon Choi, Jasvinder A. Singh, Nicola Dalbeth, Sanford Kaplan, Vandana Niyyar, Danielle Jones, Steven A. Yarows, Blake Roessler, Gail Kerr, Charles King, Gerald Levy, Daniel E. Furst, N. Lawrence Edwards, Brian Mandell, H. Ralph Schumacher, Mark Robbins, Neil Wenger, Robert Terkeltaub, 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia, Arthritis Care & Research, 2012, 64, 10
  94. 94
    Thomas Bardin, Pascal Richette, Crystal arthritis: New ACR guidelines for gout management hold some surprises, Nature Reviews Rheumatology, 2012, 9, 1, 9

    CrossRef

  95. 95
    Jasvinder A Singh, Emerging therapies for gout, Expert Opinion on Emerging Drugs, 2012, 17, 4, 511

    CrossRef

  96. 96
    H. Ralph Schumacher, Guidelines and Algorithms, Journal of Clinical Rheumatology, 2012, 18, 8, 387

    CrossRef

  97. 97
    Bianca Maria Piraccini, Michela Starace, Francesca Bruni, Onychomycosis in children, Expert Review of Dermatology, 2012, 7, 6, 569

    CrossRef

  98. 98
    Francisca Sivera, Mihir D Wechalekar, Mariano Andrés, Rachelle Buchbinder, Loreto Carmona, Interleukin-1 inhibitors for acute gout, The Cochrane Library,
  99. 99
    John HY Moi, Melonie K Sriranganathan, Christopher J Edwards, Rachelle Buchbinder, Lifestyle interventions for acute gout, The Cochrane Library,
  100. 100
    Caroline MPG van Durme, Mihir D Wechalekar, Rachelle Buchbinder, Naomi Schlesinger, Désirée van der Heijde, Robert BM Landewé, Non-steroidal anti-inflammatory drugs for acute gout, The Cochrane Library,